Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Revenue | 45.18bn | 39.00bn |
| Cost of revenue | 23.28bn | 21.04bn |
| Research and development | 3.39bn | 2.93bn |
| Selling, general and administrative | 1.89bn | 1.70bn |
| Operating income | 13.33bn | 10.42bn |
| Pre-tax income | 12.72bn | 9.97bn |
| Income tax | 1.74bn | 1.25bn |
| Net income | 10.98bn | 8.71bn |
| Earnings per share | 2.58 | 2.03 |
| Earnings per share, diluted | 2.53 | 1.98 |
| Weighted average shares | 4.25bn | 4.30bn |
| Weighted average shares, diluted | 4.34bn | 4.39bn |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12.26bn | 9.03bn | 9.29bn | 8.18bn | 7.20bn | 7.80bn | 7.46bn | 6.63bn |
| Short-term investments | 29m | 29m | 37m | 213m | 1.17bn | 1.78bn | 1.77bn | 31m |
| Current assets | 17.07bn | 13.02bn | 12.96bn | 11.99bn | 11.70bn | 13.10bn | 12.13bn | 9.62bn |
| Property, plant and equipment | 2.15bn | 2.00bn | 1.84bn | 1.74bn | 1.64bn | 1.59bn | 1.57bn | 1.51bn |
| Total assets | 61.02bn | 55.60bn | 54.93bn | 53.10bn | 52.09bn | 53.63bn | 52.28bn | 49.10bn |
| Current liabilities | 12.13bn | 10.98bn | 9.73bn | 8.94bn | 9.72bn | 10.76bn | 10.71bn | 10.14bn |
| Short-term debt | 999m | 999m | 0 | 0 | 1.01bn | 1.78bn | 1.82bn | 1.80bn |
| Long-term debt | 13.36bn | 13.46bn | 14.46bn | 14.45bn | 14.01bn | 13.80bn | 14.16bn | 12.18bn |
| Total liabilities | 29.89bn | 28.98bn | 28.98bn | 28.15bn | 28.06bn | 28.89bn | 29.56bn | 26.99bn |
| Equity | 31.13bn | 26.62bn | 25.95bn | 24.95bn | 24.03bn | 24.74bn | 22.72bn | 22.11bn |
| Shares outstanding | 4.21bn | 4.22bn | 424m | 425m | 426m | 4.28bn | 427m | 429m |
| Shares issued | 4.21bn | 4.22bn | 424m | 425m | 426m | 4.28bn | 427m | 429m |
| Treasury shares | 360m | 347m | 33m | 31m | 30m | 260m | 25m | 22m |
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Operating cash flow | 10.15bn | 7.36bn |
| Depreciation and amortisation | 333m | 329m |
| Share-based compensation | 368m | 273m |
| Capital expenditure | 688m | 440m |
| Investing cash flow | 1.04bn | −2.18bn |
| Share buybacks | 9.13bn | 6.26bn |
| Financing cash flow | −10.35bn | −4.07bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)